GIANNINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.602
EU - Europa 3.708
AS - Asia 801
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 1
Totale 11.163
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.585
RU - Federazione Russa 1.517
IE - Irlanda 525
SE - Svezia 442
PL - Polonia 405
SG - Singapore 258
HK - Hong Kong 231
IT - Italia 222
UA - Ucraina 179
DE - Germania 150
FI - Finlandia 137
CN - Cina 136
TR - Turchia 96
GB - Regno Unito 71
IN - India 65
CI - Costa d'Avorio 40
FR - Francia 17
CA - Canada 16
BE - Belgio 13
CH - Svizzera 11
NL - Olanda 9
JO - Giordania 7
VN - Vietnam 7
CZ - Repubblica Ceca 5
SC - Seychelles 5
EU - Europa 4
AU - Australia 2
NO - Norvegia 2
AT - Austria 1
CL - Cile 1
KR - Corea 1
LT - Lituania 1
MX - Messico 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.163
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.381
Fairfield 674
Chandler 542
Dublin 525
Warsaw 404
Ashburn 362
Cambridge 311
Seattle 297
Woodbridge 289
Jacksonville 264
Wilmington 255
Houston 235
Singapore 201
Ann Arbor 161
Princeton 136
Buffalo 123
Hong Kong 114
Boardman 105
Boston 98
Izmir 93
Altamura 91
Lawrence 80
Beijing 79
Mumbai 65
Medford 62
Bremen 43
Abidjan 40
Shanghai 39
San Diego 37
Falls Church 26
Norwalk 25
Andover 16
Florence 16
Washington 16
Hillsboro 15
Moscow 14
Brussels 13
Dearborn 13
Toronto 13
Auburn Hills 11
Bern 11
Los Angeles 11
Milan 11
Munich 9
New York 9
Old Bridge 8
Salerno 8
West Jordan 8
Frankfurt Am Main 7
Verona 7
Dong Ket 6
Kent 6
Brno 5
Laurel 5
Redmond 5
Saint Petersburg 5
San Mateo 5
London 4
Yubileyny 4
Ferriere 3
Grevenbroich 3
Padova 3
Paris 3
Phoenix 3
Rome 3
Tappahannock 3
Brooklyn 2
Leawood 2
Meppel 2
Modena 2
Oslo 2
Rufina 2
Banbridge 1
Bologna 1
Cairns 1
Cape May Court House 1
Central 1
Chieti 1
Civitanova Marche 1
Clifton 1
Genoa 1
Groningen 1
Hanoi 1
Helsinki 1
Kunming 1
Livorno 1
Melbourne 1
Messina 1
Mérida 1
Naaldwijk 1
Napanee 1
New Bedfont 1
Portland 1
Prescot 1
Qingdao 1
Reggio Emilia 1
Saint-Jean-sur-Richelieu 1
Sanayi 1
Seoul 1
Stanford 1
Totale 7.479
Salva come PNG Salva come JPEG
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 250
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 245
HCV and lymphoproliferation 223
Host genetic determinants in HCV-related mixed cryoglobulinemia 143
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 141
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 140
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 130
Host genetic determinants in HCV-related mixed cryoglobulinemia 125
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 124
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 123
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 121
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 119
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 118
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 116
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 114
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 114
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 113
T(14;18) translocation in chronic hepatitis C virus infection 112
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 112
Involvement of PI3K in HCV-related lymphoproliferative disorders 112
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 112
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 110
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 110
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 110
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 108
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 107
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 106
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. 105
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 105
Analysis of HCV persistence in patients with sustained virological response 105
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 104
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 104
Hepatitis C virus core protein enhances B lymphocyte proliferation 103
Hepatitis C virus-related lymphoproliferative disorders: an overview 103
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 102
Host genetic determinants in HCV-related mixed cryoglobulinemia 102
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 101
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 101
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 100
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 99
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 99
Hepatitis C virus lymphotropism and possible pathogenetic implications 96
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 96
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 96
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector 95
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 94
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 94
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 94
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 93
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis 91
Hepatitis C virus RNA localization in human carotid plaques. 91
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 90
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 90
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 89
The Hepatitis C Virus Infection as a Systemic Disease 87
Hepatitis C virus biology. 86
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 86
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 84
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 83
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx 82
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 82
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis 82
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 82
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 82
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. 81
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 79
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 78
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 77
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 77
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 76
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 76
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes 75
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 74
Could HGV infection be implicated in lymphomagenesis? 72
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 72
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 72
Hepatotropic viruses: new insights in pathogenesis and treatment 70
E' possibile la trasmissione del virus C dell'epatite nei centri di dialisi mediante il passaggio attraverso la membrana emodialitica? Risultati di uno studio preliminare 70
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 69
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 69
Reply: HCV infection and psychopathological disorders 68
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 68
Eventi Oncomolecolari nella Crioglobulinemia Mista 68
Hepatitis C virus lymphotrophism: lesson from a decade of studies 67
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells 67
Il virus dell'epatite C (HCV): l'infezione e la malattia 66
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 66
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 65
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 65
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 65
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 65
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 65
Prevalence of mixed infections by different hepatitis C genotypes in patients with hepatitis C virus-related chronic liver disease. 64
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 63
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 62
HCV infection in B-cell non-Hodgkin’s lymphoma. 62
Type C chronic hepatitis complicated by B-cell lymphoma 62
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 62
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 61
HCV and HGV infection in B-cell non-Hodgkin's lymphoma patients. 59
Totale 9.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.082 0 0 0 0 153 184 156 179 147 113 132 18
2020/2021835 105 40 71 90 14 126 16 72 74 103 68 56
2021/2022879 6 122 21 43 29 18 24 54 35 12 198 317
2022/20232.211 224 230 99 184 230 459 325 103 244 22 59 32
2023/2024658 43 99 145 41 50 83 17 132 7 11 12 18
2024/20253.629 166 591 364 834 1.674 0 0 0 0 0 0 0
Totale 11.176